Yvan Nicaise
Overview
Explore the profile of Yvan Nicaise including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
357
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tauziede-Espariat A, Ebrahimi A, Boddaert N, Pietsch T, Grajkowska W, Blau T, et al.
Brain Pathol
. 2024 Oct;
35(2):e13303.
PMID: 39442927
CIC fusions have been described in two different central nervous system (CNS) tumor entities. On one hand, fusions of CIC or ATXN1 genes belonging to the same complex of transcriptional...
2.
Le Quang M, Trinquet A, Siegfried A, De Barros A, Bauchet L, Ng S, et al.
Acta Neuropathol
. 2024 Aug;
148(1):26.
PMID: 39167187
No abstract available.
3.
Tauziede-Espariat A, Nicaise Y, Sievers P, Sahm F, von Deimling A, Guillemot D, et al.
Acta Neuropathol Commun
. 2024 Apr;
12(1):55.
PMID: 38581034
A novel methylation class, "neuroepithelial tumor, with PLAGL1 fusion" (NET-PLAGL1), has recently been described, based on epigenetic features, as a supratentorial pediatric brain tumor with recurrent histopathological features suggesting an...
4.
Bentaberry-Rosa A, Nicaise Y, Delmas C, Gouaze-Andersson V, Cohen-Jonathan-Moyal E, Seva C
Cancers (Basel)
. 2024 Jan;
16(1).
PMID: 38201456
GSCs play an important role in GBM recurrence. Understanding the resistance mechanisms in these cells is therefore crucial for radiation therapy optimization. In this study, using patient-derived GSCs, we demonstrate...
5.
Uro-Coste E, Tauziede-Espariat A, Dubucs C, Chiforeanu D, Siegfried A, Nicaise Y, et al.
Brain Pathol
. 2023 Nov;
34(3):e13223.
PMID: 37994695
We report here about two novel tumours classified as extraventricular neurocytomas (EVN) using DNA-methylation profiling, associated with NTRK2 fusions instead of the usual FGFR1 alterations so far attributed to this...
6.
Dubucs C, Rendu J, Michel-Calemard L, Menassa R, Langeois M, Nicaise Y, et al.
Neuromuscul Disord
. 2023 Nov;
33(12):978-982.
PMID: 37945483
Until recently, the disease known to be associated with THOC2 mutations was Intellectual developmental disorder, X-linked 12 (MIM300957). However, recently, fetal arthrogryposis multiplex congenita has been associated with a specific...
7.
Lemarie A, Lubrano V, Delmas C, Lusque A, Cerapio J, Perrier M, et al.
Sci Adv
. 2023 Nov;
9(44):eadi0114.
PMID: 37922359
Despite maximally safe resection of the magnetic resonance imaging (MRI)-defined contrast-enhanced (CE) central tumor area and chemoradiotherapy, most patients with glioblastoma (GBM) relapse within a year in peritumoral FLAIR regions....
8.
Tauziede-Espariat A, Uro-Coste E, Nicaise Y, Sievers P, von Deimling A, Sahm F, et al.
Acta Neuropathol Commun
. 2023 Oct;
11(1):170.
PMID: 37875973
No abstract available.
9.
Tauziede-Espariat A, Siegfried A, Nicaise Y, Dghayem D, Laprie A, Lubrano V, et al.
Acta Neuropathol
. 2023 Oct;
146(6):841-844.
PMID: 37870637
No abstract available.
10.
Tauziede-Espariat A, Uro-Coste E, Sievers P, Nicaise Y, Mariet C, Siegfried A, et al.
Acta Neuropathol Commun
. 2023 Feb;
11(1):26.
PMID: 36782314
The Central Nervous System (CNS) tumor with BCOR internal tandem duplication (ITD) has recently been added as a novel embryonal histomolecular tumor type to the 2021 World Health Organization (WHO)...